NBPF24 inhibitors represent a theoretical category of chemical entities intended to selectively interfere with the activity of the NBPF24 protein. NBPF24 is part of the Neuroblastoma BreakPoint Family, a group of proteins that have been associated with neurodevelopmental processes and are characterized by their diverse and complex genomic arrangements. While the specific functions of many NBPF proteins, including NBPF24, have not been fully delineated, the family is generally believed to be involved in the regulation of neuronal development and associated cellular mechanisms. The development of inhibitors targeting NBPF24 would require precise design to ensure that the inhibition is specific to NBPF24 and does not inadvertently affect the function of other members of the NBPF family or unrelated proteins due to sequence or functional similarities.
The creation of NBPF24 inhibitors would be predicated on a deep molecular understanding of NBPF24, including its domain structure, active sites, and interaction partners. This would likely involve the use of high-resolution techniques such as cryo-electron microscopy or X-ray crystallography to obtain a detailed three-dimensional structure of the protein. Such structural insights would be vital for identifying potential druggable sites where small molecules could bind to modulate the protein's function. Additionally, computational modeling and virtual screening could be leveraged to predict the interaction of candidate molecules with these sites, guiding the synthesis of compounds that could act as NBPF24 inhibitors. Through a combination of empirical data and in silico analysis, initial candidates for NBPF24 inhibition would be identified and synthesized for further testing.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This compound is a DNA methyltransferase inhibitor that can cause hypomethylation of DNA, potentially altering gene expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Similar to 5-azacytidine, decitabine can lead to DNA hypomethylation and could disrupt the expression of various genes. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Vorinostat is a histone deacetylase inhibitor that causes hyperacetylation of histones, potentially changing chromatin structure and gene expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is another histone deacetylase inhibitor that may result in altered gene expression through changes in chromatin accessibility. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate serves as a histone deacetylase inhibitor, potentially affecting gene expression by altering histone modification. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
Entinostat is a selective histone deacetylase inhibitor that could modulate gene expression profiles. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
Romidepsin is a histone deacetylase inhibitor that may change gene expression patterns, including potentially those of NBPF11. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
Panobinostat is a potent histone deacetylase inhibitor that could influence expression of a wide range of genes. | ||||||
Temozolomide | 85622-93-1 | sc-203292 sc-203292A | 25 mg 100 mg | $91.00 $255.00 | 32 | |
Temozolomide methylates DNA, which can lead to mispairing or breaks in DNA strands, affecting transcription and potentially gene expression. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic acid has histone deacetylase inhibitory activity, which might alter epigenetic regulation of gene expression, including NBPF11. | ||||||